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Abstract
Background: Postoperative respiratory complications (PRCs) are associated with significant morbidity, mortality, and
hospital costs. Obstructive sleep apnea (OSA), often undiagnosed in the surgical population, may be a contributing
factor. Thus, we aimed to develop and validate a score for preoperative prediction of OSA (SPOSA) based on data
available in electronic medical records preoperatively.
Methods: OSA was defined as the occurrence of an OSA diagnostic code preceded by a polysomnography procedure.
A priori defined variables were analyzed by multivariable logistic regression analysis to develop our score. Score validity
was assessed by investigating the score’s ability to predict non-invasive ventilation. We then assessed the effect of high
OSA risk, as defined by SPOSA, on PRCs within seven postoperative days and in-hospital mortality.
Results: A total of 108,781 surgical patients at Partners HealthCare hospitals (2007–2014) were studied. Predictors of
OSA included BMI >25 kg*m−2 and comorbidities, including pulmonary hypertension, hypertension, and diabetes. The
score yielded an area under the curve of 0.82. Non-invasive ventilation was significantly associated with high OSA risk
(OR 1.44, 95% CI 1.22–1.69). Using a dichotomized endpoint, 26,968 (24.8%) patients were identified as high risk for OSA
and 7.9% of these patients experienced PRCs. OSA risk was significantly associated with PRCs (OR 1.30, 95% CI 1.19–1.43).
Conclusion: SPOSA identifies patients at high risk for OSA using electronic medical record-derived data. High risk of OSA
is associated with the occurrence of PRCs.
Keywords: Perioperative obstructive sleep apnea, Prediction, Outcomes, Postoperative respiratory complications,
In-hospital mortality
Background
Obstructive sleep apnea (OSA), the most common type
of sleep-disordered breathing, is characterized by recurrent
partial or complete collapse of the upper airway during
sleep. It is associated with significant immediate and
long-term morbidity, including fragmented sleep, im-
paired daytime functioning, and reduced quality of life
[1, 2]. OSA has also been associated with other medical
conditions including hypertension [3], stroke [4], heart
failure [5, 6], type 2 diabetes [7], obesity [8], and meta-
bolic syndrome [9, 10].
OSA is a highly prevalent disease, affecting approximately
9 to 24% of the general population [11, 12]. However, these
numbers may underestimate the true prevalence of the dis-
ease, as studies have shown that a significant proportion of
OSA patients are undiagnosed [13–16].
Surgical patients with OSA are particularly vulnerable
to perioperative morbidity [17], including postoperative
respiratory complications (PRCs), as anesthesia and
surgery affect the collapsibility of the upper airway as
well as respiratory drive [18, 19]. The American Society
* Correspondence: meikermann@partners.org
1Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts
General Hospital, 55 Fruit Street, Boston, Massachusetts, USA
2Harvard Medical School, Boston, Massachusetts, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shin et al. BMC Anesthesiology  (2017) 17:71 
DOI 10.1186/s12871-017-0361-z
of Anesthesiologists (ASA) has recently updated a set of
practice guidelines for providers regarding the importance
of preoperative screening for OSA through comprehensive
review of medical records for history of comorbidities as
well as any prior sleep studies, interview with patient and/or
family, and physical examination [20]. To date, several pre-
diction scores and questionnaires have been constructed.
Those that have been validated in the perioperative period
include the Perioperative Sleep Apnea Prediction Score
(P-SAP) [21] and the STOP-Bang score [22]. Anesthesi-
ologists have also used scores, such as the Mallampati
Score, ASA Checklist, and the DES-OSA score [23] to
assess difficulty of intubation as related to a narrow
upper airway [24]. However, like P-SAP and STOP-
Bang, these scores rely on a clinical exam and there is
inconsistency in reported sensitivity and specificity of
the Mallampati score as a predictor of OSA [25]. The
currently available scores require data from an airway
exam not routinely available from clinical databases,
such as Mallampati class or thyromental distance. As a
result, there is an emphasis on patient awareness and
physician suspicion, both of which may fail to detect
OSA with high sensitivity and specificity [26]. Often,
some surgical patients do not see an anesthesiologist
prior to the day of surgery and instead are screened
preoperatively via phone interview in order to generate
or update the electronic medical record. Given the
strong associations between OSA and various comorbid
diseases [27], it may be fruitful to utilize readily avail-
able data on demographics and comorbidities to make
predictions regarding OSA risk.
The objectives of this study were to develop a prediction
score based on patient data available in hospital-based
electronic medical records, utilize the prediction score to
characterize the impact of high OSA risk on PRCs, and as-
sess whether or not intraoperative pharmacologic agents
affect the association between high OSA risk and PRCs.
We hypothesize that patients at high risk of OSA will also
have higher risk of adverse postoperative outcomes.
Methods
This study is an analysis of prospectively collected data
on file using hospital-based electronic patient data at
Massachusetts General Hospital, a tertiary care facility
and teaching hospital of Harvard Medical School, as well
as two community hospitals affiliated with Partners
HealthCare in Massachusetts, United States of America.
The protocol for this study has been previously peer-
reviewed and published [28]. This project received ap-
proval from the Partners Institutional Review Board
(Protocol #2014P000218).
As previously used for studies by our group, data from
two clinical databases and one administrative database
were retrieved and combined to provide de-identified
pre- and postoperative information: the Research Patient
Data Registry, the Anesthesia Information Management
System, and Enterprise Performance Systems Inc [29–31].
The Research Patient Data Registry contains demographic
and billing data regarding patient comorbidities and post-
operative outcome and survival. The Anesthesia Informa-
tion Management System contains physiological data
from patient monitors as well as documentation of im-
portant surgery and anesthesia-related events, including
adverse events, perioperative procedures, and drug and
fluid therapy. The Enterprise Performance Systems Inc
(EPSi) is a performance improvement and financial plan-
ning system containing data on admission and discharge
statistics. Patient data from these databases are linked
through unique patient identifiers and the variables uti-
lized for our prediction model were abstracted to form
one database. The present database spans from January
2007 to August 2014 and includes more than 145,000
surgical cases.
Subject selection
We included all surgical patients aged 18 years or older
who underwent general anesthesia and received endo-
tracheal intubation or airway management by supraglot-
tic airway device at our institution between January 2007
and August 2014 and who had removal of all airway
management devices within the operating room after the
procedure. Patients who underwent surgery in the 4 weeks
prior to the study case were excluded. Finally, all patients
with an American Society of Anesthesiologists physical
classification (ASA) score of 6 (brain-dead patients under-
going organ procurement) were excluded from the study.
Prediction model reference standard
The reference standard for the prediction model was
defined as patients with an International Statistical Clas-
sification of Diseases and Related Health Problems,
ninth revision (ICD-9) OSA diagnosis following the
appearance of a polysomnography procedural (CPT,
Current Procedural Terminology) code in our medical
databases. From this specific sequence of events, we
inferred that these patients had their clinically sus-
pected OSA diagnosis confirmed by polysomnography.
Our OSA endpoint was confirmed by a blind review of
100 total charts: 50 charts each were randomly se-
lected from those cases positive for the OSA endpoint
and those cases negative for the OSA endpoint. If
available, sleep study results were reviewed as well as
preoperative evaluation reports by anesthesiology pro-
viders and consultation notes. Diagnoses of “obstructive
sleep apnea” and/or evidence of active use of “positive
airway pressure” devices at home were considered posi-
tive for OSA.
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Set of predictor variables analyzed
A number of variables have been found to be associated with
an increased prevalence of OSA and are currently used for
different prediction tools for OSA in surgical patients. From
our clinical databases, we included the following variables in
our prediction score: age, BMI, gender, ASA score, and
medical comorbidities using ICD-9 diagnostic codes.
An additional document lists the ICD-9 diagnostic codes
used to identify patient comorbidities in more detail [see
Additional file 1]. All covariates included in the prediction
model were present within 1 year prior to surgery date.
Prediction model
Continuous, normally distributed variables were expressed
as mean ± standard deviation (SD), while ordinal as me-
dian [interquartile range, (IQR)] and categorical variables
as frequency (percentages) if not otherwise specified. Out
of the a priori defined aforementioned group of predictor
variables, we identified those variables that met an entry
criteria of p = 0.01 using a multivariable logistic regression
analysis with a forward selection procedure. The Hosmer-
Lemeshow test was used to determine the goodness of fit
of the final prediction model, with a p-value ≥ 0.05 indica-
tive of no significant difference between the observed and
expected outcome. The beta coefficient of each significant
predictor was divided by the smallest coefficient and the
results were then rounded to the nearest whole number to
define the score point value [31]. The discriminative abil-
ity of the score for OSA was assessed using the c-statistic,
which is equivalent to the area under the receiver operat-
ing characteristic curve (AUC) [32]. A cut-point was iden-
tified to optimize the sensitivity and specificity of the
score for the OSA endpoint using the Youden Index [33].
Prediction score validation
The prediction score, called the score for preoperative pre-
diction of obstructive sleep apnea (SPOSA), was in-
ternally validated using ten-fold cross-validation
approach and the root mean square error values were
averaged across all estimations of the model. In this
procedure, the study population was randomly sepa-
rated into ten equal sized samples and of these, a sin-
gle sample was reserved as the validation data for
testing. We then developed a prediction score based
on the other nine deciles of the data using the same
modeling process as in the initial approach. The
resulting score was applied in the validation sample
which we previously left out in the modeling process
and assessed the performance of the score in this sub-
group. This cross-validation procedure was repeated
ten times, with each of the ten samples used as the
validation data. We aimed to test how well the final
prediction model performed within each sample of the
original population. In addition, we calculated the
derived SPOSA for each surgical case and evaluated
its predictive value in the dataset using a logistic re-
gression model. The calculated c-statistic and the esti-
mated probabilities for OSA were determined.
As an additional assessment for the clinical predictability
of our score, we performed a multivariable logistic regres-
sion analysis to predict the outcome of non-invasive venti-
lation. In fact, recently published data suggest that the
combination of polysomnography followed by receipt of a
non-invasive ventilation device is highly specific for a true
diagnosis of OSA [34]. We identified patients with a pro-
cedure code for non-invasive ventilation within seven days
of surgery and investigated its association with OSA risk, as
defined by SPOSA.
Missing data
Twelve thousand six hundred forty five cases were
excluded from the primary analysis due to missing
data. In order to assess the impact of the excluded
cases, we re-estimated beta-coefficients and odds ra-
tios of the primary model using multiple imputation by
chained equations. Variables with missing data were im-
puted using all covariates included in the prediction score.
Five imputations were used. The model estimates were
combined using variance estimates that combine impreci-
sion both within and across imputations.
Effect of OSA risk on perioperative outcomes
The primary postoperative outcome was a composite
outcome, postoperative respiratory complications
(PRCs), defined as the incidence of reintubation, pul-
monary edema, pneumonia and/or respiratory failure
within the first seven postoperative days. The pri-
mary outcome has been previously used and vali-
dated by chart review. Events were identified by
ICD-9 diagnostic and CPT procedural codes ob-
tained from the Research Patient Data Registry data-
base [see Additional file 1]. Secondary outcomes
included the aforementioned individual outcomes and in-
hospital mortality.
With the primary exposure variable as OSA risk, defined
as the dichotomized SPOSA score, we performed un-
adjusted logistic regression analyses and analyses adjusted
for demographic variables, comorbidities, and procedure-
related variables. Variables included in our adjusted model
were the following: age, gender, BMI, ASA physical status
classification, Charlson Comorbidity Index, duration of the
surgical procedure, admission type, emergency status, dur-
ation of hypotension, procedure relative value units, volume
of intraoperative fluids, dose of anesthesia (median dose of
anesthetic agents corrected for age), opioids (calculated as
total morphine equivalent dose), vasopressors, sedatives,
neuromuscular blocking agents, neostigmine use, units of
packed red blood cell transfusion, and median values for
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plateau and peep pressures. Variables were selected based
on a priori knowledge about association patterns between
covariates, OSA, and PRCs.
Finally, to evaluate the potential effect modification by in-
traoperative neuromuscular blockade, neostigmine, opi-
oid, anesthetic, and sedative use on PRCs, we
investigated the interaction effects between OSA risk
and the intraoperative pharmacologic agent. Interaction
terms consisted of two categorical variables, one of
which was the dichotomized OSA risk classification
based on the SPOSA cut-point. Neuromuscular block-
ing agents (NMBA) and neostigmine were classified as
binary variables with respect to the use of these agents.
For propofol, inhalational anesthetic (quantified as age-
adjusted MAC), and morphine, we calculated the me-
dian dose within our population and created a binary
variable based on high versus low dose of the respective
agent. Confounder control was consistent with our
main analyses. Results are presented as an unadjusted
and multivariable-adjusted odds ratio (OR) with 95%
confidence intervals (95% CI).
Statistical analyses were conducted by using the soft-
ware STATA (Version 13.1, StataCorp, College Station,




A total of 146,288 surgical cases were identified. Of
those a total of 37,264 cases were excluded because they
either had missing values for covariates, received their
care predominantly outside the main Massachusetts
General Hospital, age was <18 years at the time of surgery,
or did not undergo endotracheal intubation or placement
of supraglottic airway device. In addition, patients with a
surgical procedure within four weeks prior to the study
case were excluded and only the first procedure remained
in the cohort. The study flow is summarized in Fig. 1.
Obstructive sleep apnea and patient characteristics
The modeling cohort is described in Table 1. Within the
entire cohort, patients were on average 54 ± 16 years old
and 56% were female. A total of 2,264 patients met our
criteria for OSA based on a combination of an OSA
diagnostic code preceded by occurrence of a polysomno-
graphy procedure code. Review of 100 randomly selected
cases yielded a positive predictive value of 86% and a
negative predictive value of 96% based on evidence of
either AHI > 5 in polysomnography reports, active use of
continuous positive airway pressure at home, or confirm-
ation of OSA diagnosis in preoperative evaluation notes.
Preoperative predictors for obstructive sleep apnea
Based on the results of an unconditional multivariable
logistic regression model with forward stepwise selection
procedure, significant predictors included BMI > 25, ASA
2 to 4, age 18 to 70, and the following comorbidities: dys-
lipidemia, chronic pulmonary disease, liver disease, hyper-
tension, congestive heart failure, pulmonary hypertension,
atrial fibrillation, diabetes, coronary artery disease, and
Fig. 1 Study flow chart
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hemiplegia/paraplegia (Table 2). The final model yielded a
c-statistic of 0.8211 (Fig. 2). The Hosmer-Lemeshow test
demonstrated a well-calibrated model (p = 0.35).
Based on the beta coefficients for the final model,
point values were assigned to the predictors and are
summarized in Table 2. The summed point values of the
developed model ranged from 0 to 49 (median 19 (IQR
15-24)) points and were on average higher in patients
who had ICD-9 codes for OSA versus who did not (me-
dian 29 (IQR 24-34) vs 19 (IQR 14-24), p < 0.001). We
provide the predicted probabilities for each integer
score [see Additional file 2]. The score led to a c-
statistic of 0.82 (Fig. 2).
Using the Youden Index [33], we calculated a score
value of 24 as cut-point for a dichotomization that
optimizes the test performance of SPOSA for OSA.
This cut-point identified 26,968 (24.8%) of the popu-
lation as high risk for OSA with a score range of 25
to 49 (median 28 (IQR 26-31)). Patients at low risk
for OSA had a range of 1 to 24 (median 17 (IQR
13-20)). The sensitivity and specificity of the SPOSA
cut-point for our reference OSA standard were 72.3%
(95% CI 70.4–74.1) and 76.2% (95% CI 76.0–76.5),
respectively. The positive predictive value and nega-
tive predictive value were 6.1% (95% CI 5.8–6.4) and
99.2% (95% CI 99.2–99.3), respectively.
In order to classify a patient as having a low, moder-
ate, and high risk for OSA, our study population was di-
vided into three equal sized groups based on SPOSA. A
total of 38,642 patients were considered low OSA risk
Table 1 Characteristics of study population
Variables OSA patients (n = 2,264) Non-OSA patients (n = 106,517) All patients
(n = 108,781)
Demographics
Age (yrs), mean (SD) 54.9 (13.8) 54.4 (16.5) 54.4 (16.4)
Gender
Male 1,143 (50.5%) 44,178 (44.3%) 48,321 (44.4%)
Female 1,121 (49.5%) 59,339 (55.7%) 60,460 (55.6%)
BMI (kg.m−2), mean (SD) 36.3 (9.4) 28.4 (7.0) 28.6 (7.1)
ASA status, median (IQR) 2 (2-3) 2 (2-3) 2 (2-3)
1 25 (1.1%) 10,386 (9.8%) 10,411 (9.8%)
2 1,147 (50.7%) 64,328 (60.4%) 65,475 (61.5%)
3 1,051 (46.4%) 30,243 (28.4%) 31,294 (28.4%)
4 40 (2.0%) 1,533 (1.4%) 1,573 (1.5%)
5 1 (0.04%) 27 (0.03%) 28 (0.03%)
Comorbidities
Acute Ischemic Stroke 61 (2.7%) 1,714 (1.6%) 1,775 (1.6%)
Arterial Hypertension 1,646 (72.7%) 44,921 (42.2%) 46,567 (42.8%)
Atrial Fibrillation 306 (13.5%) 7,025 (6.6%) 7,331 (6.7%)
Cerebrovascular Disease 205 (9.0%) 8,224 (7.7%) 8,429 (7.7%)
Chronic Pulmonary Disease 664 (29.3%) 12,680 (11.9%) 13,344 (12.3%)
Congestive Heart Failure 403 (17.8%) 7,298 (6.9) 7,701 (7.1%)
Coronary Artery Disease 336 (14.8%) 7,221 (6.8%) 7,557 (6.9%)
Dementia 16 (0.7%) 551 (0.5%) 567 (0.5%)
Diabetes Mellitus 743 (32.8%) 12,855 (12.1%) 13,598 (12.5%)
Dyslipidemia 1,438 (63.5%) 34,349 (32.2%) 35,787 (32.9%)
Hemi/Paraplegia 76 (3.4%) 2,204 (2.1%) 2,280 (2.1%)
Liver Disease 608 (26.9%) 10,091 (9.5%) 10,699 (9.8%)
Myocardial Infarction 46 (2.0%) 1,259 (1.2%) 1,305 (1.2%)
Peptic Ulcer Disease 35 (1.5%) 673 (0.6%) 708 (0.7%)
Peripheral Vascular Disease 262 (11.6%) 8,169 (7.7%) 8,431 (7.8%)
Pulmonary Hypertension 165 (7.3%) 1,630 (1.5%) 1,795 (1.7%)
All values stated as number of patients (%), unless otherwise stated
OSA obstructive sleep apnea, BMI body mass index, ASA American Society of Anesthesiologists physical classification score
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with a range of 1 to 16 (median 13 (IQR 11-15)). 38,823
patients were identified as moderate OSA risk with a
range of 17 to 23 (median 20 (18-22)). Finally, 31,316
patients were classified as high OSA risk with a range of
24 to 49 (median 27 IQR (25-31)).
Validation of prediction score
Ten-fold cross-validation was performed for internal val-
idation of our prediction model and yielded a root mean
square error value of 0.0145 across ten iterations with a
mean AUC of 0.8165.
Table 2 Prediction model for Obstructive Sleep Apnea
Predictor Odds Ratio p-value 95% Confidence Interval Score Value
Male Gender 1.24 <0.001 1.14–1.36 1
BMI (kg.m−2)
25 to <30 2.13 <0.001 1.78–2.55 4
30 to <35 4.04 <0.001 3.39–4.81 8
35+ 8.50 <0.001 7.20–10.05 12
Age (yr)
18–50 3.56 <0.001 2.68–4.71 7
50–70 2.35 <0.001 1.80–3.08 5
70–80 1.55 0.003 1.16–2.06 2
ASA
2 3.28 <0.001 2.21–4.87 6
3 3.55 <0.001 2.37–5.32 7
4 2.16 0.004 1.28–3.67 4
Arterial Hypertension 1.67 <0.001 1.49–1.86 3
Atrial Fibrillation 1.40 <0.001 1.21–1.61 2
Chronic Pulmonary Disease 1.84 <0.001 1.66–2.05 3
Congestive Heart Failure 1.35 <0.001 1.18–1.55 2
Diabetes 1.24 0.001 1.12–1.37 1
Dyslipidemia 2.14 <0.001 1.93–2.37 4
Hemiplegia/Paraplegia 1.40 0.007 1.10–1.79 2
Liver Disease 1.97 <0.001 1.77–2.18 4
Pulmonary Hypertension 1.89 <0.001 1.55–2.31 3
Coronary Artery Disease 1.20 0.007 1.05–1.38 1
Odds ratios, p-values and 95% CI are presented for those predictor variables identified as the strongest independent predictors in a multivariable binary logistic
regression model for obstructive sleep apnea. Predictors were assigned a rounded score point value in proportion to the lowest beta coefficient in the model
Fig. 2 Receiver operating characteristic (ROC) curve for prediction of obstructive sleep apnea. a ROC curve was performed for the logistic
regression model derived from significant independent predictors (AUC 0.8218). b A second ROC curve was fitted based on the composite
prediction score derived from our prediction model (AUC 0.8211)
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We further sought to assess the validity of SPOSA by
investigating its association with the incidence of non-
invasive ventilation following surgery. This approach
was based on the work of McIsaac and co-workers who
reported that the combination of a polysomnography
procedure code followed by receipt of a non-invasive
ventilation device was highly specific for a true diagnosis
of OSA (specificity of 98%) [34]. In our study, a total of
1,139 (4.2%) of patients at high risk of OSA (score >24)
received non-invasive ventilation without subsequent
reintubation within 7 days of surgery, compared with a
total of 496 (0.6%) of patients at low risk of OSA
(SPOSA ≤24). Multivariable logistic regression analyses,
which controlled for a variety of potential intraoperative
confounders, resulted in a significant association between
high OSA risk (SPOSA >24) and the outcome of non-
invasive ventilation (OR 1.44, 95% CI 1.22–1.69, p < 0.001).
Missing data
In order to account for missing confounders, the pri-
mary regression analysis was repeated using multiple im-
putations by chained equations. The association of all
previously identified independent predictors and OSA
remained significant with similar odds ratios [see Add-
itional file 3].
Association between postoperative respiratory
complications and OSA risk
A total of 5,894 (5.4%) patients experienced a PRC
within 7 days of surgery. The breakdown of individual
respiratory complications was as follows: 3,936 (3.6%)
pulmonary edema, 1,459 (1.3%) pneumonia, 1,927 (1.8%)
respiratory failure, and 410 (0.4%) reintubation. Increas-
ing OSA risk, as quantified by SPOSA in tertiles, was
significantly associated with higher odds of PRCs in an
unadjusted model (Table 3). This association remained
stable after adjustments (Table 3).
A total of 2,126 patients (7.9%) of patients identified as
high OSA risk (SPOSA > 24) experienced PRCs within
7 days following surgery, while a total of 3,768 (4.6%) of
low OSA risk (SPOSA ≤ 24) patients were positive for
this outcome (Table 4). In unadjusted and adjusted ana-
lyses, high OSA risk was significantly associated with
PRCs (adjusted OR 1.30, 95% CI 1.19–1.43, p < 0.001;
Table 4). Of the individual respiratory complications,
this effect seemed to be driven largely by pulmonary
edema (Table 4).
In-hospital death occurred in 98 (0.4%) patients with a
SPOSA > 24 and in 277 (0.3%) patients with a SPOSA ≤24.
There was no significant association between in-hospital
mortality and OSA risk (adjusted OR 0.74, 95% CI 0.53–
1.03, p = 0.071; Table 4).
Effect modification by intraoperative pharmacologic
agents
We found no significant interaction effects between OSA
risk and each of the following pharmacologic agents used in-
traoperatively: neostigmine, NMBA, inhalational anesthetic,
morphine, and propofol (Table 5).
Discussion
We have developed a novel prediction score for OSA
using data available in electronic medical records alone.
The SPOSA is based on demographic data and data on
medical comorbidities identified as predictors for OSA.
Our score yielded an AUC of 0.8211 and identified
24.8% of our population as high OSA risk based on a
cut-point of 24, which was optimized based on sensitiv-
ity and specificity for the condition of OSA. Our score
was validated internally using cross-validation and its
clinical validity was further assessed by its prediction of
non-invasive ventilation within 7 days after surgery.
The SPOSA is a weighted model containing comorbid-
ity and demographic variables known to be associated
with OSA, including: chronic pulmonary disease [35],
congestive heart failure [5, 6], diabetes [7], dyslipidemia
[36, 37], hypertension [3, 38], atrial fibrillation [39, 40],
liver disease [41], coronary artery disease [42], and pul-
monary hypertension [43, 44]. The association between
hemiplegia/paraplegia and OSA may be related to the an
association between OSA and acute ischemic stroke [4,
45]. Male gender, high BMI, and older age have also
been shown to predict OSA and are included in our
model [8, 9, 12, 46].
We identified a cut-point to optimize the test perform-
ance of the SPOSA, which led to a 72 and 76% sensitiv-
ity and specificity, respectively. We were uncertain as to
whether false positives were equally as costly as false
negatives. The true costs in healthcare can be analyzed
using the endpoint, value of care – that is, patient’s
Table 3 Association of increasing Obstructive Sleep Apnea risk and Postoperative Respiratory Complications (PRC)




Low: (1 to 16) 1,357 (3.5%) 1 1
Moderate: (17 to 23) 2,106 (5.4%) 1.58 (1.47–1.69), p < 0.001 1.14 (1.04–1.24), p = 0.004
High: (24 to 49) 2,431 (7.8%) 2.31 (2.15–2.48), p < 0.001 1.42 (1.25–1.59), p < 0.001
The results of unadjusted and adjusted multivariable logistic regression analyses are presented below as odds ratios (OR), 95% Confidence Interval (95%
CI), p-value
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outcome as a fraction of monetary costs. Patients with a
false positive diagnosis of OSA may be subsequently ex-
posed to unnecessary perioperative interventions. A false
negative OSA test carries an even higher risk for the pa-
tient, given the propensity for developing PRCs, which is
harmful for the patient and costly for the hospital. Fur-
ther studies are needed to define the consequences of
false positive and false negative screening results.
Previous scores have been developed to predict the
likelihood of OSA in a surgical patient. These scores re-
quire information derived from a clinical exam, such as
the Mallampati class or thyromental distance, in patients
prior to their scheduled procedure. The STOP-Bang [22]
and P-SAP scores [21] are well-known and validated
scores and may be used to risk stratify patients for post-
operative complications [47]. However, to the best of
our knowledge, no score for OSA exists that has been
developed from electronic medical records that does not
contain information derived from direct patient encoun-
ters or physical examinations and is applicable to a sur-
gical patient population. Further, the SPOSA is a risk
stratification tool for postoperative complications while
adjusting for procedure-related factors, including surgi-
cal complexity.
Patient information available in electronic medical re-
cords and health administrative databases confer the ad-
vantage of studying large populations and screening the
individual preoperative patient in a relatively inexpensive
and more accessible way. Current methods of detecting
OSA rely on patient-reported symptoms and physician-
led examinations. However, many surgical patients opt
for a phone interview with a non-anesthesia provider
instead of an in-person preoperative evaluation by an
anesthesia provider and thus many patients who may be
at risk for OSA are missed in the screening process due
to lack of physical exam information. Still, during these
phone interviews, information on patient demographics
and comorbidities are updated in the electronic record
and this readily available data may be used for important
screening efforts. A recent study performed amongst
non-surgical patients concluded that non-symptom medical
history was superior over patient-reported symptoms [48].
Using a new machine learning method (Supersparse Linear
Integer Model, SLIM), authors identified the following vari-
ables as predictive for OSA in a sleep-lab referred popula-
tion: older age, high BMI, diabetes, hypertension, smoker,
and male gender. Compared with symptom-based features,
a model based on history alone demonstrated a significantly
higher AUC (0.78 vs. 0.67, p < 0.0001) [48]. The findings of
Ustun and co-workers support the rationale and findings of
our study as we sought to create a prediction model based
on data available in the medical record. Our data add to the
findings of Ustun and co-workers that an instrument com-
posed of an optimal combination of comorbidities and BMI
reliably predicts OSA risk in a surgical cohort.
The performance of the SPOSA is comparable to
scores that have been developed in clinic-based set-
tings. For example, the c-statistic for STOP-Bang and
P-SAP score are 0.65 [49] and 0.79 [21], respectively,
for an AHI > 5 compared to a c-statistic of 0.82 of our
score. Of note, the STOP-Bang and P-SAP score re-
quire biological measurements to be taken during an
exam (neck circumference, thyromental distance). The
good test performance of the SPOSA – an instrument
that does not utilize biomarkers (physical exam or lab
information) – is consistent with other examples in
which scores that do not include biomarkers perform
very similarly to scores that do include such information
[50–52]. For example, in a cardiovascular risk prediction
score with and without laboratory measurements, such
Table 4 Association between Obstructive Sleep Apnea (OSA) risk and postoperative outcomes
Outcome High OSA Risk
(SPOSA >24) N (%)
Low OSA Risk
(SPOSA≤ 24) N (%)
Unadjusted
OR (95% CI), p-value
Adjusted
OR (95% CI), p-value
Postoperative Respiratory Complications 2,126 (7.9%) 3,768 (4.6%) 1.77 (1.68–1.87), p < 0.001 1.30 (1.19–1.43), p < 0.001
Pulmonary Edema 1,519 (5.6%) 2,417 (3.0%) 1.96 (1.84–2.09), p < 0.001 1.48 (1.33–1.64), p < 0.001
Pneumonia 495 (1.8%) 964 (1.2%) 1.57 (1.41–1.75), p < 0.001 1.13 (0.96–1.33), p = 0.14
Respiratory Failure 626 (2.3%) 1,301 (1.6%) 1.47 (1.34–1.62), p < 0.001 0.96 (0.83–1.11), p = 0.61
Reintubation 125 (0.5%) 285 (0.3%) 1.33 (1.08–1.64), p = 0.008 0.89 (0.65–1.22), p = 0.48
In-hospital mortality 98 (0.4%) 277 (0.3%) 1.08 (0.85–1.35), p = 0.54 0.74 (0.53–1.03), p = 0.071
Results of unadjusted and adjusted multivariable logistic regression analyses presented as odds ratio (OR), 95% Confidence Interval (95% CI), p-value
Table 5 Interaction Effects between Obstructive Sleep Apnea
(OSA) Risk and Intraoperative Pharmacologic agents
Interaction Term Association between PRC and OSA Risk
(Adjusted OR, (95% CI), p-value)
OSA Risk * Morphine Dose 1.04 (0.92–1.18), p = 0.55
OSA Risk * Age Adjusted MAC 0.98 (0.86–1.11), p = 0.72
OSA Risk * Propofol Dose 1.00 (0.88–1.13), p = 0.97
OSA Risk * NMBA Use 0.96 (0.79–1.16), p = 0.65
OSA Risk * Neostigmine Use 0.94 (0.82–1.08), p = 0.36
The results of adjusted multivariable logistic regression analyses are presented
below for the interaction term of OSA Risk and Intraoperative Pharmacologic
Agent as odds ratio (OR), 95% Confidence Interval (95% CI), p-value
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as cholesterol or c-reactive protein, predictive measures
have been very similar [50, 51], which is very important
for applications in more general settings or in regions
where laboratory data are not easily ascertainable.
The SPOSA substantially adds to other available scores
and allows providers to identify patients at increased risk
of OSA from existing preoperative data resources. Of
note, in a study by McIsaac and colleagues, the authors
demonstrate that OSA specific billing codes alone are
insufficient to identify patients with OSA [34]. There-
fore, in order to generate the SPOSA, we utilized a dif-
ferent approach: we use a combination of available data
on OSA associated comorbidities and other known pre-
dictors such as BMI, age, and gender. Our data show
that a substantially high proportion of our cohort (about
one third) presents with high risk of OSA whereas only
2.1% carried the OSA specific billing codes.
SPOSA is associated with adverse respiratory events
In our cohort of surgical patients, we also found that a
high preoperative risk of OSA, as defined by SPOSA,
was associated with increased odds of PRCs. Our results
remained stable after accounting for patient comorbidities
and perioperative factors, suggesting that the association
between high OSA risk and PRCs is likely a consequence of
OSA risk, rather than a consequence of OSA-associated
comorbidities.
OSA has been established as a risk factor for adverse
perioperative outcomes. The higher propensity of patients
with high risk for OSA towards PRCs is most likely multi-
factorial and related to a pathological imbalance of upper
airway dilation and collapse. We hypothesized that surgi-
cal patients at high risk for OSA are especially vulnerable
to multiple perioperative insults, including the effects of
sedatives, opioids, neuromuscular blocking agents, fluid
resuscitation, and more. In order to evaluate the biological
implications of high OSA risk, we performed our primary
analysis and investigated the association between high
OSA risk, as defined by SPOSA > 24, and incidence of
PRCs as a composite outcome within seven postoperative
days while controlling for several perioperative factors.
We report a significant association between high pre-
operative OSA risk, as defined by increasing SPOSA
values, and increased rate of PRCs in non-cardiac surgery
patients. Of note, the primary driver of this association ap-
peared to stem from a significant association between high
preoperative OSA risk and pulmonary edema. High OSA
risk did not appear to have a significant impact on the
remaining components of our composite primary out-
come: reintubation, respiratory failure, and pneumonia.
Our findings are supported by other work in the literature,
which have primarily associated a medical diagnosis of
sleep-disordered breathing with cardiopulmonary compli-
cations [53, 54].
Emergent intubation or reintubation is a common
respiratory endpoint studied in the context of OSA
patients and many studies have demonstrated a signifi-
cant association [17, 55]. However, our findings differ
in that our increased rate of reintubation observed
among patients with a high SPOSA score was, although in-
creased, not statistically significant. The absence of a signifi-
cant association between high OSA risk and reintubation
may be in part due to the significantly increased rates of
postoperative noninvasive ventilation among high OSA risk
patients found in our study. While the authors of a meta-
analysis of the association between OSA and postoperative
outcomes did not specifically investigate noninvasive venti-
lation, they also found a non-significant association be-
tween reintubation and OSA patients, consistent with our
findings and that of an updated meta-analysis [54, 56].
Biological implications
We found that high preoperative risk of OSA increases
the risk of developing respiratory complications within
7 days following surgery, a finding that is consistent with
several studies in the literature. This association was
stable across various methods of SPOSA categorization.
The significant association between high OSA risk and
PRCs may be in part driven by the high rate of negative
pressure pulmonary edema in this vulnerable group of
patients following surgery [57, 58]. Another potential
driving force of pulmonary edema formation is the
phenomenon of overnight rostral fluid shifts. Redolfi et
al. measured leg fluid volumes and performed overnight
polysomnography in healthy, non-obese men and found
that overnight changes in lower extremity edema corre-
lated significantly with AHI and neck circumference
[59]. Perioperative fluid shifts should expose patients
with high preoperative scores to an increased risk for
perioperative airway obstruction, but rostral fluid shifts
secondary to the positioning of patients during surgery
and in the hospital may significantly contribute to ad-
verse outcomes.
In contrast to a few studies [17, 55] which reported
lower perioperative mortality among OSA patients, we
did not find a significant association of in-hospital mor-
tality among patients identified as high risk for OSA.
One possible explanation for the difference in findings
may lie in the populations studied. Nearly half of the
NIS populations studied by Mokhlesi et al. were com-
posed of patients receiving care at non-academic prac-
tices. In contrast, our study population is derived solely
from a large academic institution and its two close affili-
ates in Boston, Massachusetts. In addition to differences
in institutional practice, variations in hospital volumes
may also drive the observed differences in in-hospital
mortality [60]. Our data support the view that OSA is a
clinically meaningful disorder in perioperative medicine.
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Strength and limitations
The SPOSA was derived from a large study cohort and a
large number of patients with ICD-9 codes for OSA,
allowing us to robustly develop a prediction score for
OSA. Our database contains a variety of surgical proced-
ure types and methods of anesthesia, thus increasing the
generalizability of the study results and applicability of
our prediction score model. In addition, the validity of
our score has been assessed by its prognostic ability –
that is, its ability to predict non-invasive ventilation early
after surgery, an outcome that is known to occur more
frequently amongst patients with OSA [61].
Several limitations have to be considered when inter-
preting our results. The SPOSA relies on the investiga-
tion of electronic patient data on file. Thus, our findings
depend on the quality of the database, which is suscep-
tible to measurement biases. There is potential for vari-
ability in the input of billing diagnoses and codes. This
database has been used in previous studies [29–31] and
demonstrated to have high specificity following verifica-
tion of diagnostic codes. We have confirmed the accuracy
of our unique combination of diagnostic and procedural
codes in capturing patients with known OSA by medical
record review. Nevertheless, it is possible that information
is left out of some patients’ charts and consequently, our
database of our composite outcomes and independent var-
iables. While our work has been validated internally and
has demonstrated to predict an outcome well associated
with OSA, our score has not yet been validated in an
external population or tested for its prediction of AHI, the
gold standard for OSA diagnosis. Future studies by our
group will be directed towards utilizing electronic medical
record data to predict OSA as measured by AHI.
Clinical implications
The SPOSA can be used as a preoperative screening
instrument in patients prior to hospital admission, with-
out the need of an in-person airway physical exam. Our
findings of increased adverse outcomes among patients
identified as high risk of OSA have important implications
for members of the perioperative team. It is imperative
that patients at greater surgical vulnerability be identified
preoperatively. This tool may prompt providers to pursue
further diagnostic evaluation prior to surgery as well as
any planned treatment interventions, including an “OSA
bundle” [62]. Given the increased risk of adverse re-
spiratory outcomes among high risk OSA patients,
perioperative providers should administer postopera-
tive opioids cautiously [62] and utilize continuous
positive airway pressure therapy in the PACU to miti-
gate postoperative opioid associated respiratory de-
pression [63].
In addition, SPOSA may further be utilized by hospital
administrators and clinicians to guide allocation of key
resources, including staff and monitoring equipment, as
patients identified as high risk of OSA are flagged for
the perioperative OSA bundle.
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